Eli Lilly & Co $59.56

down 0.00


23/4/2014 06:40 PM  |  NYSE : LLY  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get LLY Trend Analysis - it has underperformed the S&P 500 by 17%

Partner Headlines

  1. Earnings Scheduled For April 24, 2014

    Benzinga
  2. Big Pharmas Swap Specialties

    IBD
  3. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  4. Benzinga's M&A Chatter for Tuesday April 22, 2014

    Benzinga
  5. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  6. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  7. Pharma Deal Frenzy: A Bid to Boost Profits, Cut Risk

    FoxBusiness
  8. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  9. Novartis, Glaxo Swap Units; Lilly Buying Animal Biz

    IBD
  10. Stock Futures Mixed And Busy; Allergan, Netflix, Glaxo Climb

    IBD
  11. Novartis Announces Multi-Billion-Dollar Revamp

    FoxBusiness
  12. US Stock Futures Edge Higher Ahead Of McDonald's Earnings

    Benzinga
  13. Stock Futures Steady Amid Raft of Health M&A

    FoxBusiness
  14. Wall Street Ticks Up as Traders Parse News Deluge

    FoxBusiness
  15. ELI LILLY

    IBD
  16. No Legwork Mondays – Takeda, Eli Lilly, And Actos

    Benzinga
  17. Market Wrap For April 14: Markets Surge on Positive Retail Data, Citi Earnings

    Benzinga
  18. Lilly, Takeda must pay $9 bil

    IBD
  19. Ethical Drug Stocks Are Struggling

    IBD
  20. UPDATE: BMO Capital Upgrades Eli Lilly

    Benzinga
  21. Takeda, Lilly to 'Vigorously Challenge' Actos Ruling

    FoxBusiness
  22. Benzinga's Top Upgrades

    Benzinga
  23. Takeda Responds to $6B Verdict in Diabetes Drug Case

    Benzinga
  24. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest ...

    Benzinga
  25. Pfizer Breast-Cancer Drug Scores, But Street Cautious

    IBD
  26. Market Wrap For April 3: Markets Winning Streak Fails To Extend To Five ...

    Benzinga
  27. Wide Moat Stocks: Protection In A Correction

    YCharts
  28. UPDATE: Cowen & Company Upgrades Eli Lilly

    Benzinga
  29. Benzinga's Top Upgrades

    Benzinga
  30. Biotech Auxilium Boosts Position In Men's Health Care

    IBD
  31. Lilly Expands Generic Deal With Prasco

    FoxBusiness
  32. UPDATE: Bank of America Reiterates on Eli Lilly and Co. Following Alimta ...

    Benzinga
  33. Merck Snags Baxter Executive As CFO

    FoxBusiness
  34. Box, Online Storage Service Provider, Files For IPO

    IBD
  35. Which Pharmas Can Keep Up Dividend-Buybacks?

    YCharts
  36. Forest Laboratories' Recovery

    GuruFocus
  37. Pfizer Breast-Cancer Drug To Show If It's For Real

    IBD
  38. Pharma Patent Cliff: Why Worst Seems Over

    YCharts
  39. Elanco Announces Agreement to Acquire Lohmann Animal Health; Lowers FY ...

    Benzinga
  40. Actavis Q4 Beats Street; Guidance Affirmed For Now

    IBD
  41. Eli Lilly up on lung cancer trial

    IBD
  42. Market Wrap For February 19: Stocks Close Lower, Nasdaq Ends Winning Streak

    Benzinga
  43. Lilly Drug Ramucirumab Boosts Lung Cancer Survival

    IBD
  44. Stocks Stage Quiet, Mixed Open; Eli Lilly Up, U.S. Steel Tanks

    IBD
  45. Actavis, Valeant, Jazz: New Roles For Specialty Pharma

    IBD
  46. #PreMarket Primer: Friday, January 31: Emerging Market Turmoil Spills Over ...

    Benzinga
  47. Eli Lilly

    IBD
  48. Market Wrap For January 30: Markets Focus on Good News

    Benzinga
  49. Lilly's Cymbalta to Trigger 'Severe' Sales Slide

    FoxBusiness
  50. UPDATE: Eli Lilly Posts Drop In Q4 Profit

    Benzinga
Trading Center